[HTML][HTML] FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

…, WJG Oyen, F Giammarile, K Tatsch, W Eschner… - European journal of …, 2015 - Springer
The purpose of these guidelines is to assist physicians in recommending, performing, interpreting
and reporting the results of FDG PET/CT for oncological imaging of adult patients. PET …

Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease

…, M Schmidt, R Mielke, W Eschner… - Journal of Nuclear …, 2002 - Soc Nuclear Med
Hexamethylpropyleneamine oxime (HMPAO) SPECT and 18 F-FDG PET depict similar
aspects of perfusion and metabolic abnormalities in Alzheimer’s disease (AD), but the …

EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid …

H Hänscheid, C Canzi, W Eschner, G Flux… - European journal of …, 2013 - Springer
The EANM Dosimetry Committee Series “Standard Operational Procedures for Pre-Therapeutic
Dosimetry” (SOP) provides advice to scientists and clinicians on how to perform patient-…

Lacrimal Glands May Represent Organs at Risk for Radionuclide Therapy of Prostate Cancer with [177Lu]DKFZ-PSMA-617

M Hohberg, W Eschner, M Schmidt, M Dietlein… - Molecular imaging and …, 2016 - Springer
Purpose Calculating the absorbed dose is important for the determination of risk and
therapeutic benefit of internal radiation therapy. The aim of this study was to perform image-based …

Treatment of refractory Hodgkin's lymphoma patients with an iodine-131–labeled murine anti-CD30 monoclonal antibody

…, K Schomaecker, T Fischer, W Eschner… - Journal of Clinical …, 2005 - ascopubs.org
Purpose Hodgkin's lymphoma (HL) has been demonstrated to be a good target for immunotherapy
since lymphocyte activation markers such as CD30 are expressed in high numbers …

Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?

C Kobe, W Eschner, M Wild, I Rahlff… - Nuclear medicine …, 2010 - journals.lww.com
Aim The use of radioiodine therapy is common in the treatment of benign thyroid disease.
Council directive Euratom 97/43 requires that for all medical exposure of individuals for …

Smoking upregulates α4β2* nicotinic acetylcholine receptors in the human brain

…, F Jessen, C Schütz, M Reinhardt, W Eschner… - Neuroscience …, 2008 - Elsevier
The role of the α4β2* nicotinic acetylcholine receptors (nAChR) in tobacco addiction in
humans is largely unresolved. We visualized brain α4β2* nicotinic acetylcholine receptors of …

Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine …

…, M Dietlein, M Faust, H Stützer, W Eschner… - Thyroid, 2006 - liebertpub.com
Background: The aim of the study was to analyze retrospectively the incidence of postradioiodine
immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in …

Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4

M Dietlein, W Eschner, F Gruenwald… - Nuklearmedizin …, 2016 - europepmc.org
The procedure guideline for radioiodine therapy of differentiated thyroid cancer (version 4)
was developed in the consensus of a representative expert group. This fulfils the level S1 (…

Development of hypothyroidism during long‐term follow‐up of patients with toxic nodular goitre after radioiodine therapy

…, C Keller, C Schneider, W Eschner… - Clinical …, 2012 - Wiley Online Library
Objective To investigate the cure rate and incidence of hypothyroidism of radioiodine treatment
with a calculated dose regimen and an intended thyroid dose of 150 Gy in patients with …